Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 174,757 |
|
|||||
| News | - | ||||||
| Day High | 3.98 | Low High |
|||||
| Day Low | 3.76 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Pyxis Oncology Inc | PYXS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.16 | -4.05% | 3.79 | 23:00:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.90 | 3.76 | 3.98 | 3.79 | 3.95 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,457 | 174,757 | US$ 3.85 | US$ 672,772 | - | 1.35 - 6.85 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:33:13 | 2 | US$ 3.95 | USD |
Pyxis Oncology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 167.98M | 44.32M | - | 0 | -73.79M | -1.66 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Pyxis Oncology News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PYXS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.53 | 4.10 | 3.50 | 3.88 | 502,696 | 0.26 | 7.37% |
| 1 Month | 4.15 | 4.33 | 3.44 | 3.85 | 366,420 | -0.36 | -8.67% |
| 3 Months | 4.93 | 6.18 | 3.44 | 4.48 | 506,894 | -1.14 | -23.12% |
| 6 Months | 1.85 | 6.85 | 1.64 | 4.50 | 626,874 | 1.94 | 104.86% |
| 1 Year | 3.04 | 6.85 | 1.35 | 4.01 | 399,564 | 0.75 | 24.67% |
| 3 Years | 19.00 | 19.00 | 1.10 | 4.25 | 586,238 | -15.21 | -80.05% |
| 5 Years | 19.00 | 19.00 | 1.10 | 4.25 | 586,238 | -15.21 | -80.05% |
Pyxis Oncology Description
| Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. |
